MENU
+Compare
TELA
Stock ticker: NASDAQ
AS OF
Jun 12, 04:55 PM (EDT)
Price
$1.85
Change
-$0.02 (-1.07%)
Capitalization
139.76M

TELA TELA Bio Forecast, Technical & Fundamental Analysis

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy... Show more

TELA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TELA with price predictions
Jun 11, 2025

Aroon Indicator for TELA shows an upward move is likely

TELA's Aroon Indicator triggered a bullish signal on June 11, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 113 similar instances where the Aroon Indicator showed a similar pattern. In of the 113 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on May 16, 2025. You may want to consider a long position or call options on TELA as a result. In of 110 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

TELA moved above its 50-day moving average on May 20, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TELA crossed bullishly above the 50-day moving average on May 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where TELA advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TELA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TELA broke above its upper Bollinger Band on June 04, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.983) is normal, around the industry mean (24.242). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.093) is also within normal values, averaging (42.497).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TELA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TELA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
TELA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TELA is expected to report earnings to fall 29.60% to -17 cents per share on August 06

TELA Bio TELA Stock Earnings Reports
Q2'25
Est.
$-0.18
Q1'25
Missed
by $0.05
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.02
Q2'24
Missed
by $0.05
The last earnings report on May 08 showed earnings per share of -25 cents, missing the estimate of -20 cents. With 66.14K shares outstanding, the current market capitalization sits at 139.76M.
A.I. Advisor
published General Information

General Information

a commercial stage medical technology company, which focuses on designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1 Great Valley Parkway
Phone
+1 484 320-2930
Employees
227
Web
https://www.telabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWEAX14.64N/A
N/A
PACE International Em Mkts Eq A
CSIIX8.68N/A
N/A
Copeland International Small Cap I
ANODX23.35N/A
N/A
American Century Small Cap Growth R6
AFCHX17.24N/A
N/A
American Century Focused Intl Gr C
TPISX12.74N/A
N/A
Nuveen Quant Intl Small Cap Eq Premier

TELA and Stocks

Correlation & Price change

A.I.dvisor tells us that TELA and HBIO have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELA and HBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELA
1D Price
Change %
TELA100%
-2.60%
HBIO - TELA
27%
Poorly correlated
-2.72%
TFX - TELA
27%
Poorly correlated
-2.37%
GMED - TELA
25%
Poorly correlated
-1.09%
ALC - TELA
25%
Poorly correlated
-0.42%
ZBH - TELA
25%
Poorly correlated
-0.72%
More